Hu Shu-Woan, Lai Hsiang-Ru, Liao Pao-Hsin
Department of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
AIDS Patient Care STDS. 2004 Oct;18(10):587-93. doi: 10.1089/apc.2004.18.587.
This study investigated and compared Taiwanese dental students' knowledge of hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV infection, attitudes toward infected patients, and important factors associated with the willingness to treat infected patients. In 2001, a self-administered questionnaire survey was conducted on all 1930 dental students enrolled from seven dental schools in Taiwan, with a response rate of 54.4%. Multiple logistic regression analysis was applied to assess the relationship between multiple factors and willingness to treat. Multivariate analysis was used to compare knowledge levels and the willingness. Of the respondents, 80%, 75%, and 49% were willing to treat HBV-, HCV-, and HIV-infected patients, respectively, and differences among the percentages were statistically significant. Students were less knowledgeable about HCV infection compared to HBV and HIV infection. Factors significantly associated with willingness to treat HBV- or HCV-infected patients were: feeling morally responsible and being able to treat infected patients safely. Those feeling morally responsible (odds ratio [OR] = 33.0, 95% confidence interval [CI] = 15.2, 71.8) and those being able to treat infected patients safely (OR = 4.1, 95% CI = 1.7, 9.9) were more willing to treat HIV patients. Taiwanese dental students were more willing to treat HBV- and HCV-infected patients than to treat HIV-infected patients.
本研究调查并比较了台湾牙科学生对乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和艾滋病毒感染的了解、对感染患者的态度以及与治疗感染患者意愿相关的重要因素。2001年,对台湾七所牙科学校招收的所有1930名牙科学生进行了一项自填式问卷调查,回复率为54.4%。应用多元逻辑回归分析来评估多种因素与治疗意愿之间的关系。使用多变量分析来比较知识水平和治疗意愿。在受访者中,分别有80%、75%和49%的人愿意治疗HBV、HCV和艾滋病毒感染患者,这些百分比之间的差异具有统计学意义。与HBV和艾滋病毒感染相比,学生对HCV感染的了解较少。与治疗HBV或HCV感染患者意愿显著相关的因素是:感到道德上有责任以及能够安全地治疗感染患者。那些感到道德上有责任的人(优势比[OR]=33.0,95%置信区间[CI]=15.2,71.8)和那些能够安全地治疗感染患者的人(OR=4.1,95%CI=1.7,9.9)更愿意治疗艾滋病毒患者。台湾牙科学生更愿意治疗HBV和HCV感染患者,而不是艾滋病毒感染患者。